Published: August 02, 2011
AHF: Victory! Boehringer Ingelheim to Increase AIDS Drug Program Rebates
LOS ANGELES - (BUSINESS WIRE) - AIDS
Healthcare Foundation (AHF), the largest global AIDS
organization, today lauded German multinational drug giant Boehringer
Ingelheim (BI) for being among the first drug companies to
voluntarily increase its drug pricing rebates for the network of
hard-hit AIDS Drug Assistance Programs (ADAP), which currently have more
than 8,800 people on waiting lists to access lifesaving antiretroviral
medicines. According to the ADAP Crisis Task Force (ACTF), which
first announced BI's actions earlier today, "The agreement extends
additional discounts and rebates on HIV medications produced by
Boehringer Ingelheim, beyond existing ones mandated by health reform and
included in previous agreements, through 2013. The agreement also
extends price freezes on HIV medications purchased by ADAPs. In
addition, Boehringer Ingelheim and the ACTF continue negotiations and
expect to provide additional discounts and rebates to troubled ADAPs."
"Boehringer Ingelheim's action earlier today is a watershed moment in
the AIDS drug crisis. We commend BI executives for their realism and
leadership for being among the first to address this crisis by
voluntarily increasing their drug rebates for ADAP," said Michael
Weinstein, President of AIDS Healthcare Foundation. "BI's action
should also serve as a halcyon call to others-notably BMS, Gilead,
Johnson & Johnson and Merck-to do more to address the ADAP crisis by
increasing their own rebates. AHF will be working hard to motivate those
companies to follow BI's lead."
At its annual general meeting earlier this year, Abbott Laboratories'
CEO Miles D. White announced that Abbott would be increasing its rebate
for ADAP by eight percent, however, AHF officials have been unable to
later confirm Abbott's action. AHF believes that the Abbott rebate
increase came as a result of contract expiration and re-negotiation. The
BI increase appears to be a voluntary effort of the company to alleviate
the ADAP crisis, which makes it an even more groundbreaking move.
"We urge other AIDS groups to join us in appealing to all AIDS drug
makers to follow the path to improved ADAP access blazed in 2011 by
Abbott and BI with their increased rebates," added AHF's Weinstein.
Over the past several years, AHF has mounted ongoing drug pricing
advocacy efforts targeting several of the major drug companies. This
advocacy included posting "Boehringer Ingelheim: Do the Right Thing on
AIDS" billboards surrounding BI's corporate offices in Ingelheim am
Rhein, Germany. The billboards include the image of a red ribbon and the
words: "Boehringer Ingelheim Mach das Richtige," as well as the website
address: www.2boehringer.org.
The website provides the public with further information about the
campaign, as well as the opportunity to send an e-letter to Ms.
Christina Boehringer, Chairman of the Shareholders' Committee. The
website and letter are accessible in both German and English.
AIDS
Healthcare Foundation (AHF), the largest global AIDS organization,
currently provides medical care and services to more than 174,000
individuals in 27 countries worldwide in the US, Africa, Latin
America/Caribbean, the Asia/Pacific region and Eastern Europe. www.aidshealth.org

AHF Assoc. Dir. of Communications
Lori Yeghiayan
Office:
+1-323-308-1834
Cell: +1-323-377-4312
loriy@aidshealth.org
or
AHF
Communications Director
Ged Kenslea
Office:
+1-323-308-1833
Cell: +1-323-791-5526
gedk@aidshealth.org
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News